Reports required by government auditing standards and the uniform guidance for the year ended June 30, 2018

This is an audit of Clemson University’s compliance with the types of compliance requirements described in the OMB Compliance Supplement that could have a direct and material effect on each of the University’s major federal programs. The University’s major federal programs are identified in the summary of auditor’s results section of the accompanying schedule of findings and questioned costs

XSEDE: eXtreme Science and Engineering Discovery Environment Third Quarter 2012 Report

The Extreme Science and Engineering Discovery Environment (XSEDE) is the most advanced, powerful, and robust collection of integrated digital resources and services in the world. It is an integrated cyberinfrastructure ecosystem with singular interfaces for allocations, support, and other key services that researchers can use to interactively share computing resources, data, and expertise.This a report of project activities and highlights from the third quarter of 2012.National Science Foundation, OCI-105357

Properties and Applications of Graphene and Its Derivatives

Graphene is a two-dimensional, one-atom-thick material made entirely of carbon atoms, arranged in a honeycomb lattice. Because of its distinctive mechanical (e.g., high strength and flexibility) and electronic (great electrical and thermal conductivities) properties, graphene is an ideal candidate in myriad applications. Thus, it has just begun to be engineered in electronics, photonics, biomedicine, and polymer-based composites, to name a few. The broad family of graphene nanomaterials (including graphene nanoplatelets, graphene oxide, graphene quantum dots, and many more) go beyond and aim higher than mere single-layer (‘pristine’) graphene, and thus, their potential has sparked the current Special Issue. In it, 18 contributions (comprising 14 research articles and 4 reviews) have portrayed probably the most interesting lines as regards future and tangible uses of graphene derivatives. Ultimately, understanding the properties of the graphene family of nanomaterials is crucial for developing advanced applications to solve important challenges in critical areas such as energy and health

Molecular modeling of drug delivery systems based on carbon nanostructures: structure, function, and potential applications for anticancer complexes of Pt(II)

The medication with Pt(II) drugs (cisplatin, carboplatin, and oxaliplatin) has been an effective alternative for treating cancers due to their notable inhibition of cancer cells growth and the prevention of metastasis. Nevertheless, the low selectivity of these metallodrugs for malignant cells produces severe side effects, which limit this chemotherapy. In this context, carbon nanohorns (CNHs) have been considered potential nanovectors for drugs, since they present low toxicity, drug-loading capacity, biodegradation routes, and biocompatibility when oxidized. However, there is still a lack of studies regarding the molecular behavior of these nanocarriers on cell membranes. The present work aims to characterize the interactions between inclusion complexes drug@CNH, which are formed by platinum drugs encapsulated in CNHs, and plasma membranes by using molecular dynamics simulations. The results demonstrated that the van der Waals contribution played a primary role (∼74%) for the complex stability, which explain the confined dynamics of drugs inside the CNHs. The free energy profiles revealed an endergonic character of the drug release processes from CNHs, in which the energy barrier for oxaliplatin release (~24 kcal mol–1 ) was ~30% larger than those for carboplatin and cisplatin (~18 kcal mol-1 ). The simulations also showed four stages of the interaction mechanism CNH--membrane: approach, insertion, permeation, and internalization. Despite the low structural disturbance of the membranes, the free energy barrier of ∼55 kcal mol-1 for the CNHs translocation indicated that this transport is kinetically unfavorable by passive process. The in silico experiments evidenced that the most likely mechanism of cisplatin delivery from CNHs involve the approach and insertion stages, where the nanovector adheres on the surface of cancer cells, as reported in in vitro studies. After this retention, the drug load may be slowly released in the tumor site. Finally, simulations of the cellular uptake of Pt(II) drugs also pointed out significant energy barriers (~30 kcal mol-1 ) for this process, which reflects their low permeability in membranes as discussed in experimental studies. In addition to reinforcing the potential of CNH as nanovector of Pt(II) drugs, the results presented in this thesis may assist and drive new experimental studies with CNHs, focusing on the development of less aggressive formulations for cancer treatments.A medicação com fármacos a base de Pt(II) (cisplatina, carboplatina e oxaliplatina) tem sido uma alternativa efetiva para tratar cânceres devido à sua notável inibição do crescimento de células cancerosas e a prevenção de metástases. No entanto, a baixa seletividade dessas metalodrogas por células cancerosas gera severos efeitos colaterais. Nesse contexto, nanohorns de carbono (CNHs) têm sido considerados potenciais nanovetores de fármacos, devido a baixa toxicidade, capacidade de carreamento de fármacos, rotas de biodegradação, e biocompatibilidade quando oxidados. Porém, existe uma carência de estudos tratando o comportamento desses nanocarreadores em biomembranas. Esse trabalho tem como objetivo caracterizar as interações entre complexos de inclusão fármaco@CNH, formados por fármacos de Pt(II) encapsulados em CNHs, e membranas usando simulações por dinâmica molecular. Os resultados demonstraram que a contribuição de van der Waals teve um papel primário (∼74%) na estabilidade dos complexos, o que explica a dinâmica confinada dos fármacos dentro dos CNHs. Os perfis de energia livre revelaram o caráter endergônico da liberação dos fármacos a partir de CNHs, nos quais a barreira de energia para a liberação da oxaliplatina (~24 kcal mol– 1 ) é ~30% maior do que aquelas para carboplatina e cisplatina. As simulações mostraram quatro estágios do mecanismo de interação CNH-membrana: aproximação, inserção, permeação e internalização. Apesar do baixo distúrbio estrutural das membranas, a barreira de energia livre de ∼55 kcal mol-1 para a translocação de CNHs indicou que esse transporte é desfavorável cineticamente via o processo passivo. Os experimentos in silico evidenciam que o mecanismo mais provável de entrega de cisplatina a partir de CNHs envolve a aproximação e inserção, onde o nanovetor adere na superfície de células cancerosas, como reportado em estudos in vitro. Após essa retenção, a carga de fármaco deve ser ligeiramente liberada no tumor. As simulações de captação celular de fármacos de Pt(II) também apontaram barreiras de energia significativas (∼30 kcal mol-1 ) para esse processo, o que reflete a baixa permeabilidade deles em membranas como discutido em estudos experimentais. Além de reforçar o potencial de CNHs como nanovetores de fármacos de Pt(II), os resultados apresentados nessa tese podem auxiliar e impulsionar novos estudos com CNHs, focando no desenvolvimento de formulações menos agressivas para tratamentos de câncer.FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerai

ICR ANNUAL REPORT 2022 (Volume 29)[All Pages]

This Annual Report covers from 1 January to 31 December 202

Inverted Colloidal Crystal Scaffolds New Substitutes for Bone Tissue Engineering

Bone is a highly organised and specialised connective tissue with natural ability to self-heal and regain functionality. This capacity is, however, exposed to a great number of threats that can critically damage bone’s health and trigger the need for bone substitutes. The present thesis aimed at the production of new bone scaffolds for tissue regeneration using the Inverted Colloidal Crystal (ICC) structure as model system. ICCs are 3D structures, resultant from Colloidal Crystals (CC) inverse replication, that exhibit uniform pore size, interconnected network and whose architectural design enhances the cellular environment and vascular ingrowth. Reported here is the use of organic (chitosan/chitin nanowhiskers) and inorganic (hydroxyapatite) building materials to develop scaffolds comprising ceramic, polymeric and composite matrices. Firstly, polystyrene microspheres are produced by simple microfluidic, assembled in hexagonal close packed CC and then used as templates for all scaffolds production. Ceramic based ICCs were developed using an hydroxyapatite solgel system and sintering route that allowed simultaneous template calcination and matrix formation. Polymeric based ICCs were subjected to hydrolytic degradation after being produced with different molecular weight chitosans in order to understand polymer influence on the scaffolds structural stability. Considering bone´s composite nature, ICCs were constructed using hydroxyapatite nanorods suspended in chitosan solutions. Also, structures whose materials have an imprinted liquid crystalline organization provided by chitin nanowhiskers were developed inspired by bone collagen arrangement that contributes to the tissue hierarchical architecture. The morphological, biological and mechanical evaluation of such scaffolds contributes to establish the path for the development of new ICC based products with potential to complement or replace the currently clinically used bone substitutes and in that way constitute valuable solutions for bone tissue regeneration